Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

480 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cardiac amyloidosis: in search of the ideal diagnostic tool.
Mavrogeni SI, Vartela V, Ntalianis A, Vretou R, Ikonomidis I, Tselegkidou M, Paraskevaidis I, Markousis-Mavrogenis G, Noutsias M, Rigopoulos A, Kolovou G, Kastritis E. Mavrogeni SI, et al. Among authors: kastritis e. Herz. 2021 Apr;46(Suppl 1):9-14. doi: 10.1007/s00059-019-04871-5. Epub 2019 Dec 3. Herz. 2021. PMID: 31796976 Review. English.
Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine.
Gavriatopoulou M, Terpos E, Kastritis E, Briasoulis A, Gumeni S, Ntanasis-Stathopoulos I, Sklirou AD, Malandrakis P, Eleutherakis-Papaiakovou E, Migkou M, Trougakos IP, Dimopoulos MA. Gavriatopoulou M, et al. Among authors: kastritis e. Clin Exp Med. 2022 May;22(2):319-323. doi: 10.1007/s10238-021-00746-4. Epub 2021 Jul 20. Clin Exp Med. 2022. PMID: 34283338 Free PMC article.
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment.
Terpos E, Gavriatopoulou M, Ntanasis-Stathopoulos I, Briasoulis A, Gumeni S, Malandrakis P, Fotiou D, Papanagnou ED, Migkou M, Theodorakakou F, Roussou M, Eleutherakis-Papaiakovou E, Kanellias N, Trougakos IP, Kastritis E, Dimopoulos MA. Terpos E, et al. Among authors: kastritis e. Blood Cancer J. 2021 Aug 2;11(8):138. doi: 10.1038/s41408-021-00530-3. Blood Cancer J. 2021. PMID: 34341335 Free PMC article.
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors.
Zagouri F, Terpos E, Fiste O, Liontos M, Briasoulis A, Katsiana I, Skafida E, Markellos C, Kunadis E, Andrikopoulou A, Kaparelou M, Koutsoukos K, Gavriatopoulou M, Kastritis E, Trougakos IP, Dimopoulos MA. Zagouri F, et al. Among authors: kastritis e. Breast. 2021 Dec;60:58-61. doi: 10.1016/j.breast.2021.08.017. Epub 2021 Aug 28. Breast. 2021. PMID: 34481366 Free PMC article.
Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study.
Terpos E, Gavriatopoulou M, Fotiou D, Giatra C, Asimakopoulos I, Dimou M, Sklirou AD, Ntanasis-Stathopoulos I, Darmani I, Briasoulis A, Kastritis E, Angelopoulou M, Baltadakis I, Panayiotidis P, Trougakos IP, Vassilakopoulos TP, Pagoni M, Dimopoulos MA. Terpos E, et al. Among authors: kastritis e. Cancers (Basel). 2021 Sep 6;13(17):4480. doi: 10.3390/cancers13174480. Cancers (Basel). 2021. PMID: 34503290 Free PMC article.
Myeloma patients with COVID-19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine.
Gavriatopoulou M, Terpos E, Malandrakis P, Ntanasis-Stathopoulos I, Briasoulis A, Gumeni S, Fotiou D, Papanagnou ED, Migkou M, Theodorakakou F, Eleutherakis-Papaiakovou E, Kanellias N, Trougakos IP, Kastritis E, Dimopoulos MA. Gavriatopoulou M, et al. Among authors: kastritis e. Br J Haematol. 2022 Jan;196(2):356-359. doi: 10.1111/bjh.17841. Epub 2021 Sep 16. Br J Haematol. 2022. PMID: 34528249 Free PMC article.
Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study.
Gavriatopoulou M, Terpos E, Ntanasis-Stathopoulos I, Briasoulis A, Gumeni S, Malandrakis P, Fotiou D, Migkou M, Theodorakakou F, Eleutherakis-Papaiakovou E, Kanellias N, Kastritis E, Trougakos IP, Dimopoulos MA. Gavriatopoulou M, et al. Among authors: kastritis e. Blood Adv. 2021 Nov 9;5(21):4398-4405. doi: 10.1182/bloodadvances.2021005444. Blood Adv. 2021. PMID: 34529762 Free PMC article. Clinical Trial.
Utilization and tolerance of beta-blockers among patients with AL amyloidosis.
Briasoulis A, Stamatelopoulos K, Petropoulos I, Patras R, Theodorakakou F, Gavriatopoulou M, Ntalianis A, Dimopoulos MA, Kastritis E. Briasoulis A, et al. Among authors: kastritis e. Amyloid. 2022 Mar;29(1):31-37. doi: 10.1080/13506129.2021.1981281. Epub 2021 Sep 22. Amyloid. 2022. PMID: 34549676
Cardiac amyloidosis presenting with coronary artery embolization.
Papageorgiou C, Tsagalou E, Baraboutis I, Tampakis K, Kastritis E, Dimopoulos MA. Papageorgiou C, et al. Among authors: kastritis e. Rev Cardiovasc Med. 2021 Sep 24;22(3):883-889. doi: 10.31083/j.rcm2203094. Rev Cardiovasc Med. 2021. PMID: 34565086 Free article.
480 results